Zolpidem

This classification denotes a sedative and hypnotic with the molecular formula C19H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7K383OQI23, chemically known as n,n,6-trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide but generally known as zolpidem, which bears US NIH Compound Identifier 5732. European Medicines Agency schedules Zolpidem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00183MIG. The term ZOLPIDEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules zolpidem in its Anatomical Therapeutic Chemical (ATC) Classification. ZOLPIDEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zolpidem under HS 29339990 and SITC 51577. As of Q4 2014, ZOLPIDEM remains the US FDA Preferred Term for this commodity. Zolpidem bears US NLM identifiers UMLS ID C0078839 and NCI Concept Code C62000. SMILES: O=C(N(C)C)CC1N2C(NC1C1CCC(CC1)C)CCC(C2)C.